Search in:

Advanced search

Cancer Management and Research Volume 9, 2017 - Issue

Submit an article Journal homepage

Open access

134

Views

CrossRef citations to date

Altmetric

Original Research

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

Zhong Lin1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Wei-Ze Lv1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Si-Yang Wang2 Department of Radiation Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Jin-Lin Zou3 Department of Surgical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Yun-Yan Con1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Zhi-Hui Wang1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Mei Xiao1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China

Pei-Jian Peng1 Department of Medical Oncology, The Fifth Affiliated Hospital of Sun-Yat-Sen University, Zhuhai, Guangdong, People’s Republic of ChinaCorrespondence[email protected]

show all

Pages 671-677 | Published online: 20 Nov 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

TorreLABrayFSiegelRLGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
PubMed Web of Science ®Google Scholar
ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
PubMed Web of Science ®Google Scholar
NSCLC Meta-Analyses Collaborative GroupChemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trialsJ Clin Oncol200826284617462518678835
PubMed Web of Science ®Google Scholar
Cancer Genome Atlas Research NetworkComprehensive molecular profiling of lung adenocarcinomaNature2014511751154355025079552
PubMed Web of Science ®Google Scholar
DingLGetzGWheelerDASomatic mutations affect key pathways in lung adenocarcinomaNature200845572161069107518948947
PubMed Web of Science ®Google Scholar
KwakELBangYJCamidgeDRAnaplastic lymphoma kinase inhibition in non-small-cell lung cancerN Engl J Med2010363181693170320979469
PubMed Web of Science ®Google Scholar
ChinLPSooRASoongROuSHTargeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancerJ Thorac Oncol20127111625163023070242
PubMed Web of Science ®Google Scholar
PazaresLGDeMFDediuMPARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerJ Clin Oncol201331232895290223835707
PubMed Web of Science ®Google Scholar
CiuleanuTBrodowiczTZielinskiCMaintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 studyLancet200937496991432144019767093
PubMed Web of Science ®Google Scholar
TsudaHHashiguchiYNishimuraSPhase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancerBr J Cancer20049161032103715292935
PubMed Web of Science ®Google Scholar
KodamaJTakemotoMSekiNPhase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancerInt J Gynecol Cancer20081851037104118021215
PubMed Web of Science ®Google Scholar
CaoWXuCLouGA phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancerJpn J Clin Oncol200939958258719509000
PubMed Web of Science ®Google Scholar
KoshiyamaMKinezakiMUchidaTSumitomoMChemosensitivity testing of a novel platinum analog, nedaplatin (254-S), in human gynecological carcinomas: a comparison with cisplatinAnticancer Res2005256C4499450216334133
PubMed Web of Science ®Google Scholar
RinaldiMCauchiCGridelliCFirst line chemotherapy in advanced or metastatic NSCLCAnn Oncol200617Suppl 5v64v6716807466
PubMed Web of Science ®Google Scholar
BoulikasTVougioukaMCisplatin and platinum drugs at the molecular levelOncol Rep20031061663168214534679
PubMed Web of Science ®Google Scholar
OzkokAEdelsteinCLPathophysiology of cisplatin-induced acute kidney injuryBiomed Res Int2014201496782625165721
PubMed Web of Science ®Google Scholar
AranyISafirsteinRLCisplatin nephrotoxicitySemin Nephrol200323546046413680535
PubMed Web of Science ®Google Scholar
KurataTTamuraKYamamotoNCombination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancerBr J Cancer200490112092209615150564
PubMed Web of Science ®Google Scholar
BaldwinCMPerryCMPemetrexed: a review of its use in the management of advanced non-squamous non-small cell lung cancerDrugs200969162279230219852529
PubMed Web of Science ®Google Scholar
HazarikaMWhiteRMJohnsonJRPazdurRFDA drug approval summaries: pemetrexed (Alimta)Oncologist20049548248815477632
PubMed Web of Science ®Google Scholar
CohenMHJohnsonJRWangYCSridharaRPazdurRFDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancerOncologist200510636336815967829
PubMed Web of Science ®Google Scholar
CohenMHCortazarPJusticeRPazdurRApproval summary: pemetrexed maintenance therapy of advanced/metastatic nonsquamous, non-small cell lung cancer (NSCLC)Oncologist201015121352135821148615
PubMed Web of Science ®Google Scholar
MubarakNGaafarRShehataSA randomized, phase 2 study comparing pemetrexed plus best supportive care versus best supportive care as maintenance therapy after first-line treatment with pemetrexed and cisplatin for advanced, non-squamous, non-small cell lung cancerBMC Cancer20121242323006447
PubMed Web of Science ®Google Scholar
ScagliottiGVParikhPvon PawelJPhase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small cell lung cancerJ Clin Oncol200826213543355118506025
PubMed Web of Science ®Google Scholar
ZhangXLuJXuJPemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysisRespirology201318113113922882698
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date